Solid Biosciences is trading 5.13% down at $9.61, with no clear company-specific announcement, earnings release, regulatory decision, or analyst action identified for August 28, 2026.
- Second-quarter results were released August 6; the investor-relations press-release page was updated August 24.
- Broader-market indicators are mixed and relatively subdued, without clearly tracking the decline.
- Recheck for delayed news or additional filings; the catalyst remains unconfirmed.